BRIEF published on 10/26/2026 at 17:03, 1 day 10 hours ago IntegraGen Maintains Its Operations Pending the Court of Appeal's Decision Shareholders Court Of Appeal Judicial Reorganization Genomics IntegraGen
BRIEF published on 10/05/2026 at 19:22, 22 days 8 hours ago IntegraGen: Decision expected on the divestment plan Judicial Reorganization IntegraGen Commercial Court Takeover Bids Decision Expected
BRIEF published on 09/11/2026 at 20:45, 1 month 16 days ago IntegraGen: two takeover bids filed in receivership Judicial Reorganization Genomics IntegraGen Resumption Commercial Court Of Évry
BRIEF published on 06/15/2026 at 20:31, 4 months 12 days ago IntegraGen is heading towards receivership to ensure its survival. Sustainability Judicial Reorganization Genomics Industrial Partnerships Strategic Activities
BRIEF published on 02/20/2026 at 20:20, 8 months 7 days ago IntegraGen: Annual Review and Continued Strategic Refocusing Revenue Treasury Certifications Profitability Biopharma
BRIEF published on 10/29/2025 at 17:50, 11 months 29 days ago IntegraGen: Lower Results, Reduced Expenses in the First Half of 2025 Financial Results Treasury Cost Reduction Genomics CLIA/CAP Certification
BRIEF published on 07/02/2025 at 07:35, 1 year 3 months ago IntegraGen Reports Decline in Sales and Cash Reserves Sales Decline Operational Costs IntegraGen Financing Needs Genomic Analyses
PRESS RELEASE published on 07/02/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases IntegraGen reports sales of €2.5 million in the first half of 2025, a 31% decrease in sequencing activities at Évry and challenges with cash position leading to exploration of strategic options Sales Cash Position Strategic Options IntegraGen Decrease
BRIEF published on 01/15/2025 at 18:49, 1 year 9 months ago IntegraGen revenue down for 2024 Treasury Growth Turnover Genomics SeqOIA
PRESS RELEASE published on 01/15/2025 at 18:44, 1 year 9 months ago Inside Information / Information on annual revenues IntegraGen, an OncoDNA Group company, reports 27% revenue drop in 2024 due to SeqOIA services cessation. Cash position at €1.9m. Growth seen outside SeqOIA Cash Position Growth Prospects Revenue Drop SeqOIA IntegraGen
Published on 10/28/2026 at 02:55, 35 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 40 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 3 hours 50 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 4 hours 5 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/28/2026 at 02:25, 1 hour 5 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 AGM Chair and Group CEO address
Published on 10/28/2026 at 02:19, 1 hour 11 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: September 2026 quarter update
Published on 10/27/2026 at 22:40, 4 hours 49 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 5 hours ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 6 hours 55 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 18:00, 9 hours 30 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 17:45, 9 hours 45 minutes ago First contract signed in Belgium for the construction of a 170 MW / 340 MWh battery energy storage system (BESS), in a temporary consortium with Eiffage Énergie Systèmes
Published on 10/27/2026 at 17:45, 9 hours 45 minutes ago Deezer delivers second consecutive quarter of revenue growth and upgrades its FY26 outlook
